C07D 233/22
Radicals substituted by oxygen atoms
C07D233/22 (Radicals substituted by oxygen atoms) appears on 173 US grants and 117 published applications in this corpus.
Search patents in C07D- Granted patents
- 173
- Published applications
- 117
- Assignees
- 127
- Inventors
- 509
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 5 | 0 |
| 1978 | 2 | 0 |
| 1979 | 3 | 0 |
| 1980 | 5 | 0 |
| 1981 | 5 | 0 |
| 1982 | 4 | 0 |
| 1983 | 3 | 0 |
| 1984 | 3 | 0 |
| 1985 | 4 | 0 |
| 1986 | 3 | 0 |
| 1987 | 3 | 0 |
| 1988 | 1 | 0 |
| 1989 | 5 | 0 |
| 1990 | 4 | 0 |
| 1991 | 5 | 0 |
| 1992 | 4 | 0 |
| 1993 | 4 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 3 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 5 | 0 |
| 2000 | 7 | 0 |
| 2001 | 3 | 1 |
| 2002 | 5 | 2 |
| 2003 | 4 | 10 |
| 2004 | 1 | 7 |
| 2005 | 4 | 10 |
| 2006 | 2 | 5 |
| 2007 | 5 | 9 |
| 2008 | 6 | 3 |
| 2009 | 3 | 7 |
| 2010 | 7 | 6 |
| 2011 | 6 | 6 |
| 2012 | 3 | 4 |
| 2013 | 6 | 3 |
| 2014 | 2 | 5 |
| 2015 | 6 | 4 |
| 2016 | 2 | 4 |
| 2017 | 3 | 1 |
| 2018 | 1 | 5 |
| 2019 | 1 | 3 |
| 2020 | 4 | 4 |
| 2021 | 1 | 5 |
| 2022 | 4 | 5 |
| 2023 | 0 | 6 |
| 2024 | 1 | 2 |
| 2025 | 3 | 0 |
| 2026 | 2 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compounds for the treatment of bacterial infections and potentiation of antibiotics8 Sep 2026US 12,728,105 B2Georgia State University Research Foundation, Inc.
- α1A-adrenergic receptor agonists and methods of use1 Sep 2026US 12,723,038 B2CuraSen Therapeutics, Inc.
- Longer-lived ruthenium olefin metathesis catalysts supported by hemi-labile carbene ligands14 Oct 2025US 12,440,831 B2The Trustees of the California State University
- Allosteric activators of the ALPHA1A-adrenergic receptor12 Aug 2025US 12,384,751 B2The Cleveland Clinic Foundation
- Process for the synthesis of lofexidine8 Jul 2025US 12,351,558 B2Medichem, S.A.
- Substituted 1,1'-biphenyl compounds, analogues thereof, and methods using same14 Nov 2024US 2024/0374595 A1Arbutus Biopharma Corporation
- Discrete peg constructs9 May 2024US 2024/0148721 A1
- Biphenyl pyrrolidine and biphenyl dihydroimidazole derivatives for inhibiting activity of 5-ht7 serotonin receptor, and pharmaceutical composition comprising same as active ingredient7 Dec 2023US 2023/0390247 A1Korea Institute of Science and Technology
- Alpha1a-adrenergic receptor agonists and methods of use5 Oct 2023US 2023/0312524 A1CuraSen Therapeutics, Inc.
- Reversible streptavidin based analyte enrichment system for use in crosslinking mass spectrometry analysis7 Sep 2023US 2023/0280352 A1Technische UniversitäT Berlin
Most cited
By later US patents
- Cis-imidazolines63US 6,734,302 B2Hoffmann-La Roche Inc. · 2004
- Apoptosis promoters52US 7,973,161 B2Abbott Laboratories · 2011
- Compounds47US 5,153,210 ABeecham Group Limited · 1992
- Inhibitors of farnesyl-protein transferase47US 5,780,488 AMerck & Co., Inc. · 1998
- Cis-imidazolines46US 6,617,346 B1Hoffmann-La Roche Inc. · 2003